Olaparib With Ceralasertib in Recurrent Osteosarcoma
Status:
Recruiting
Trial end date:
2025-06-01
Target enrollment:
Participant gender:
Summary
This study is being done in order to evaluate the effectiveness of using two drugs (olaparib
and ceralasertib) to treat patients with osteosarcoma that has not responded to treatment or
has come back after treatment
The names of the study drugs involved in this study are:
- Olaparib
- Ceralasertib